Advanced

A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.

Lindén, Ola LU ; Kurkus, Jan LU ; Garkavij, Michael LU ; Cavallin-Ståhl, Eva LU ; Ljungberg, Michael LU ; Nilsson, Rune LU ; Ohlsson, Tomas G LU ; Sandberg, Bengt; Strand, Sven-Erik LU and Tennvall, Jan LU (2005) In Cancer Biotherapy & Radiopharmaceuticals 20(4). p.457-466
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Cancer Biotherapy & Radiopharmaceuticals
volume
20
issue
4
pages
457 - 466
publisher
Mary Ann Liebert, Inc.
external identifiers
  • pmid:16114994
  • wos:000231487500010
ISSN
1557-8852
language
English
LU publication?
yes
id
6f2ec2dc-efaf-43ee-b086-200ff310f19d (old id 142626)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16114994&dopt=Abstract
date added to LUP
2007-07-10 09:05:11
date last changed
2016-04-16 04:51:18
@article{6f2ec2dc-efaf-43ee-b086-200ff310f19d,
  author       = {Lindén, Ola and Kurkus, Jan and Garkavij, Michael and Cavallin-Ståhl, Eva and Ljungberg, Michael and Nilsson, Rune and Ohlsson, Tomas G and Sandberg, Bengt and Strand, Sven-Erik and Tennvall, Jan},
  issn         = {1557-8852},
  language     = {eng},
  number       = {4},
  pages        = {457--466},
  publisher    = {Mary Ann Liebert, Inc.},
  series       = {Cancer Biotherapy & Radiopharmaceuticals},
  title        = {A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and (90)y-labeled rituximab in patients with refractory B-cell lymphoma.},
  volume       = {20},
  year         = {2005},
}